Expanding Genetic Testing Guidelines Could Identify More Patients with Increased Risks of Cancer
Current testing guidelines miss new gene-cancer associations that have the potential to impact care, study says.
Read MorePosted by Steve Halasey | Oct 8, 2019 | Breast |
Current testing guidelines miss new gene-cancer associations that have the potential to impact care, study says.
Read MorePosted by Steve Halasey | Oct 1, 2019 | Breast, Pancreatic, Prostate |
Some women may benefit from risk assessment, counseling, and testing for rare genetic mutations, says USPSTF.
Read MorePosted by Steve Halasey | Sep 24, 2019 | Pancreatic |
Updated guidelines from the National Comprehensive Cancer Network recommend genetic testing for all patients with pancreatic cancer.
Read MorePosted by Steve Halasey | Sep 17, 2019 | Leukemia, Microarray Systems |
Strong concordance with standard-of-care methods shows how the Saphyr mapping system can transform cytogenetic workflows and improve blood cancer treatment.
Read MorePosted by Steve Halasey | Sep 17, 2019 | Prostate |
Trial results confirm the potential benefits of using biomarkers to guide care for men with metastatic castration-resistant prostate cancer.
Read More